Skip to main content
2023 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Integrated Informatics Institute
Back
Handout

Educational Sessions

Intensive Studies for Recertification

Board Certification Activities

Dream of the Endless: Updates in Procedural Sedation

Wednesday, December 6, 2023
8:00 AM – 9:30 AM  
Location: ACC, Room 201b, Level 2
CE Credits 1.50 contact hours
Activity #: 0204-0000-23-309-L01-P
Activity Type: Application-based
Target Audience: Pharmacist, Board-Certified Pharmacist
NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

This session will review the aspects of procedural sedation and commonly used agents for both sedation and analgesia in all age groups. Case-based examples with polling questions will be used throughout the session to enhance learning, gauge the audience’s baseline understanding and reflection of their current practice, as well as assess implementation of some of the concepts discussed during the presentation. Faculty will provide information on novel practices that have the potential to impact future practice in this area.

This activity is approved for Board Certified Pediatric Pharmacy Specialist (BCPPS) and Board Certified Critical Care Pharmacist (BCCCP) recertification credit.

Learning Objectives:

  • Evaluate the most current literature regarding agents used for sedation and analgesia in the setting of procedural sedation.
  • Discuss patient-specific variables that have the potential to impact the safety and efficacy of the various pharmacotherapy options used in procedural sedation.
  • Critique procedural sedation pharmacotherapy implementation strategies with the goal of optimizing pharmacokinetic and pharmacodynamic principles.
  • Recognize options for alternative routes of administration and potential considerations based on patient-specific factors.
  • Identify important components that should be included in workflows and protocols for procedural sedation (e.g., stocking atomizers for intranasal administration, antidote availability, bedside monitoring).